Strong Pulse: Indraprastha Medical’s Q4 Profits Jump, Dividend Boosts Investor Vitality

Indraprastha Medical Corporation Ltd. has announced third-quarter ending March 2025 financial results with strong operation and profitability figures. The healthcare services firm reported operating revenue of ₹3.34 billion in the March quarter, reflecting smooth and consistent growth in its operating core healthcare business. Net profit after tax (PAT) was ₹410.1 million in the quarter under review, reflecting strong year-on-year growth of 31.6%.

 

The board approved a final dividend of ₹4.50 per share for the year, or a 45% payment on the face value of ₹10. The action is in line with the company's policy of rewarding shareholders on a trend of rising dividend payments in the recent past.

 

Though the numbers depict strong growth in top line and bottom line, analysts have pointed out a large contribution of non-operating income during the quarter, which could not be sustained in the long run. Otherwise, the operational fundamentals of the company are good, with a sound balance sheet and stable growth in earnings.

 

The record date for the purpose of final dividend shall be declared at the ensuing Annual General Meeting upon shareholders approval, and the date for AGM shall be communicated by the company in due course of time. At the prevailing market price of ₹440.25 per share, the yield on the dividend is around 1.83%.

 

Source: MarketsMojo, Moneycontrol, INDmoney